# Venatorx Pharmaceuticals, Inc. — Form D

Venatorx Pharmaceuticals, Inc. of MALVERN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-27. The offering totals $16.4M, of which $15.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-02-27
- Form: D
- Accession: 0001590501-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $16.4M
- Amount sold: $15.0M
- Remaining: $1.4M
- Investors: 2
- Date of first sale: 2023-02-17
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-474330

## Issuer

- Name: Venatorx Pharmaceuticals, Inc.
- CIK: 0001590501
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 30 SPRING MILL DRIVE, MALVERN, PA, 19355
- Phone: 610-644-8935

## Officers, directors & promoters (20)

| Name | Role | Location |
| --- | --- | --- |
| Michael C Diem | Director | Malvern, PA |
| Ezra J Felker | Executive Officer | Malvern, PA |
| SHELLEY J CHU | Director | SAN DIEGO, CA |
| Timothy J Haines | Director | Malvern, PA |
| Tomas C Heyman | Director | Malvern, PA |
| Christopher J Burns | Director | Malvern, PA |
| Christopher J Burns | Executive Officer | Malvern, PA |
| Daniel C Pevear | Director | Malvern, PA |
| Daniel C Pevear | Executive Officer | Malvern, PA |
| Anthony J Meehan | Executive Officer | Malvern, PA |
| Sergei J Petukhov | Director | Malvern, PA |
| Martin J Heidecker | Director | Malvern, PA |
| Timothy J Henkel | Executive Officer | Malvern, PA |
| Michael J Diem | Director | Malvern, PA |
| Vincent J Milano | Director | Malvern, PA |
| Carlo J Rizzuto | Director | Malvern, PA |
| Tim J Henkel | Executive Officer | Malvern, PA |
| Luigi J Xerri | Director | Malvern, PA |
| Luigi J Xerri | Executive Officer | Malvern, PA |
| James J Murphy | Executive Officer | Malvern, PA |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-07-13](https://search.stillhousedata.com/formd/0001806270-23-000001) | D/A | $48.2M | $35.0M |
| [2022-12-22](https://search.stillhousedata.com/formd/0001590501-22-000004) | D/A | $24.7M | $24.7M |
| [2022-09-02](https://search.stillhousedata.com/formd/0001590501-22-000003) | D | $24.5M | $12.7M |
| [2022-04-04](https://search.stillhousedata.com/formd/0001590501-22-000001) | D | $60.0M | $34.0M |
| [2018-11-05](https://search.stillhousedata.com/formd/0001590501-18-000001) | D/A | $47.1M | $27.1M |
| [2017-07-25](https://search.stillhousedata.com/formd/0001590501-17-000001) | D | $42.0M | $21.9M |
| [2013-12-04](https://search.stillhousedata.com/formd/0001590501-13-000001) | D | $4.0M | $3.4M |

## More

- [CIK 1590501 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1590501&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001590501-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.